Latest "Treatment Solutions Network" News Stories

13:47 EST 16th January 2019 | BioPortfolio

Here are the most relevant search results for "Treatment Solutions Network" found in our extensive news archives from over 250 global news sources.

More Information about Treatment Solutions Network on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Treatment Solutions Network for you to read. Along with our medical data and news we also list Treatment Solutions Network Clinical Trials, which are updated daily. BioPortfolio also has a large database of Treatment Solutions Network Companies for you to search.

Showing "Treatment Solutions Network" News Articles 1–25 of 24,000+


ECI Telecom Chosen as a Partner for Optical Solutions in Ericsson's Transport Offering

PETACH TIKVA, Israel, Sept. 5, 2018 /PRNewswire/ -- ECI, a global provider of ELASTIC Network® solutions for service providers, critical infrastructures and data center operators, Read more...

6 Opioid Use Disorder Treatment Stocks

Lawsuits have been filed against many pharmaceutical companies for the opioid crisis, but this doesn’t solve opioid addiction problems. As such, here the Investing News Network looks at six opioid use disorder treatment stocks. The post 6 Opioid Use Disorder Treatment Stocks appeared first on Investing News Network.

Network Monitoring Market - Global Forecast to 2023: Optimizing Business Operations Through ...

DUBLIN, Oct. 22, 2018 /PRNewswire/ -- The "Network Monitoring Market by Offering (Equipment and Solutions & Services), Bandwidth (1 & 10 Gbps, 40 Gbps, 100 Read more...

Inspire expands research solutions to help inform patient-focused drug development

The health care social network Inspire is expanding its research solutions to help life science stakeholders integrate the patient voice and experience into research.

Children's Miracle Network Hospitals: Behind the Scenes of a Video Shoot with Chloe

SOURCE: Aflac DESCRIPTION:As a national ambassador for Children’s Miracle Network Hospitals, Chloe, age 11, is just one of 10 million children treated each year at Children’s Miracle Network Hospitals.  This past week, Chloe took to the sky to fly to Columbus, GA, home of Aflac, a Children’s Miracle Network Hospitals partner to participate in a video shoot to create her story on surviving c...

Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO (patisiran), for the Treatment of ATTR Amyloidosis

Arbutus Biopharma (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that the Company’s lipid nanoparticle (LNP) licensee, Alnylam Pharmaceuticals, (Nasdaq:ALNY), announced that their new drug application (NDA) for ONPATTRO, an RNAi therapeutic, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of heredit...

ICP-OES Assists with Reliable Analysis of Electrolytic Etching Solutions

The analysis of electrolytic etching solutions is a challenge for a large number of laboratories. Complex matrices from concentrated acids and spectral interferences make it difficult to screen for possible impurities. Regular analysis of the solutions is crucial to the quality of subsequent production processes since even the slightest impurities can have severe consequences. The automotive and a...

Inspire expanding research solutions in aim to better inform patient-focused drug development

The health care social network Inspire is expanding its research solutions to help life science stakeholders integrate the patient voice and experience into research.

OWKIN launches world's largest AI-powered medical research network

(LaunchSquad) OWKIN today announced the world's largest AI-powered medical research network. The OWKIN Loop Network is comprised of 44 prestigious hospitals and research institutions across the US and Europe, including Cleveland Clinic and Mount Sinai. The network enables researchers to train predictive models on real-world data at scale and transfer knowledge to a collective intelligence, benefit...

Progenics Receives FDA Approval for Rare Tumor Treatment

AZEDRA treats patients 12 and older with two different types of rare tumors–pheochromocytoma or pragaglioma–and is the first FDA approved treatment for this type of treatment. The post Progenics Receives FDA Approval for Rare Tumor Treatment appeared first on Investing News Network.

Discussing Advances in Chemo Brain Treatment

Cancer Network spoke with Tracy D. Vannorsdall, PhD and Patricia Ganz, MD about treatment methods for cancer-related cognitive impairment.

Network Atlas Launches Map of Global Internet Infrastructure

IRVINE, Calif., Nov. 1, 2018 /PRNewswire/ -- A new service will radically amplify the ability of network professionals around the world to identify potential network Read more...

UVA partners with health systems in AVIA network’s Medicaid Transformation Project

University of Virginia Health System is partnering with more than 20 other health systems in the AVIA network's Medicaid Transformation Project to develop financially sustainable solutions to improving the health of the nearly 75 million Americans who receive Medicaid.

Inspire Medical Announces Aetna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea

Inspire Medical (NYSE:INSP) a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that Aetna Inc., one of the leading health plans in the United States, will provide coverage for the Company’s Inspire therapy, effective immediately.  Aetna’s plan provides cov...

Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.$133 Million Deal Adds European Early Development Center of Excellence to Global Network

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has agreed to acquire Juniper Pharmaceuticals, Inc. (NASDAQ: JNPR), including its Nottingham, U.K.-based Juniper Pharma Services division. When combined with Catalent’s existing industry-leading drug develo...

Balboa Horizons To Become In-Network Provider for More Clients

COSTA MESA, Calif. (PRWEB) November 07, 2018 Balboa Horizons, a residential addiction-treatment center, will become an in-network provider to more premier insurers starting Nov. 7, 2018 with First Health, Multiplan and PHCS. Humana will be added Dec. 1. The costs of substance-abuse treatme...

Even Going To In-Network Hospitals Can Land You With A Big Medical Bill

When patients go to an in-network facility, they can still be treated by an out-of-network medical professional--anesthesia or pathology claims being among the most common.

AbbVie is accused of paying kickbacks, using a stealthy network of nurses to promote Humira

In a wide-ranging scheme, AbbVie used a combination of old-fashioned kickbacks to doctors and a stealthy network of nurses to illegally boost prescriptions of its best-selling Humira treatment.

Foundations Recovery Network Names New CEO

BRENTWOOD, Tenn. (PRWEB) August 01, 2018 Matt Feehery has been named Chief Executive Officer at Foundations Recovery Network (FRN) and Vice President, Addiction Treatment Services, Behavioral Health Division of Universal Health Services (UHS) , effective July 30, 2018. He will lead the Add...

TraceLink Expands Supply Chain Solutions Portfolio

Announces $93 million investment round to accelerate expansion of information-sharing network platform across life sciences

Quadrant Biosciences announces collaboration on research into treatment of ASD

Quadrant Biosciences, Inc., an emerging life science company based in Syracuse, N.Y., today announced its collaboration with the Autism Speaks® Autism Treatment Network and its university research partners on research into the treatment of autism spectrum disorder.

AbbVie Notches FDA Approval for Endometriosis Pain Treatment

The company said that the drug has a projected availability date of August 2018 in US retail pharmacies. It is the first FDA-approved oral treatment for alleviating pain associated with endometriosis. The post AbbVie Notches FDA Approval for Endometriosis Pain Treatment appeared first on Investing News Network.

IVF services slashed in England as NHS bosses cut costs – The Guardian

The GuardianIVF services slashed in England as NHS bosses cut costsThe GuardianA growing number of areas in England have axed IVF treatment on the NHS and the proportion offering the recommended three cycles of treatment has fallen to just over one in 10, the Guardian can reveal. The data, gathered by the Fertility Network UK ...Health warning on NHS treatment banThe Timesall 5 news articles

Carilion Clinic Joins TriNetX Network to Expand Clinical Research and Collaboration Opportunities

TriNetX, the global health research network, will announce the latest addition to its research network: Carilion Clinic, a not-for-profit healthcare organization based in Roanoke, Virginia. By joining the network, Carilion will enhance its researchers’ ability to quickly execute clinical trials and collaborate with other industry TriNetX network members. Carilion, serves nearly one million res...

Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

AbstractObjectiveTo provide a complete toxicity profile, toxicity spectrum, and a safety ranking of immune checkpoint inhibitor (ICI) drugs for treatment of cancer.DesignSystematic review and network...

Quick Search


News Quicklinks